Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Generalized Tonic-clonic Seizures”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Post-approval studies (Phase 4)Study completedNCT03288129
What this trial is testing

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Partial Onset SeizuresSecondarily Generalized SeizuresPrimary Generalized Tonic-Clonic Seizures
Eisai Inc. 54
Not applicableStudy completedNCT02736162
What this trial is testing

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

Who this might be right for
EpilepsyPartial-Onset SeizuresPrimary Generalized Tonic-Clonic Seizures
Eisai Inc. 61
Large-scale testing (Phase 3)Study completedNCT00236886
What this trial is testing

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

Who this might be right for
EpilepsyEpilepsies, PartialEpilepsy, Generalized+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 49
Testing effectiveness (Phase 2)Study completedNCT01118962
What this trial is testing

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 39
Large-scale testing (Phase 3)Study completedNCT00160550
What this trial is testing

Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures

Who this might be right for
Generalized Convulsive Epilepsy
UCB Pharma 154
Not applicableStudy completedNCT03059329
What this trial is testing

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

Who this might be right for
Partial Seizures (With or Without Secondary Generalized Seizures)Primary Generalized Tonic-clonic Seizures
Eisai Co., Ltd. 3,809
Not applicableStudy completedNCT03059381
What this trial is testing

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

Who this might be right for
Partial Seizures (With or Without Secondary Generalized Seizures)Primary Generalized Tonic-clonic Seizures
Eisai Co., Ltd. 519
Testing effectiveness (Phase 2)Looking for participantsNCT07130786
What this trial is testing

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Who this might be right for
SeizuresPrimary Motor CortexBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+2 more
Ayal A. Aizer, MD 150
Large-scale testing (Phase 3)Study completedNCT03678753
What this trial is testing

Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

Who this might be right for
Primary Generalized Epilepsy
SK Life Science, Inc. 169
Post-approval studies (Phase 4)Study completedNCT00043901
What this trial is testing

Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug

Who this might be right for
Epilepsy, Tonic-Clonic
GlaxoSmithKline 141
Large-scale testing (Phase 3)Study completedNCT01393743
What this trial is testing

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

Who this might be right for
Seizure Disorder Generalized Tonic Clonic
Eisai Inc. 163
Large-scale testing (Phase 3)Study completedNCT02408549
What this trial is testing

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 239
Large-scale testing (Phase 3)Study completedNCT02849626
What this trial is testing

Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures

Who this might be right for
Partial-Onset or Primary Generalized Tonic-Clonic Seizures
Eisai Inc. 180
Not applicableStudy completedNCT04252846
What this trial is testing

Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

Who this might be right for
Idiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures
Eisai Limited 191
Large-scale testing (Phase 3)Study completedNCT00104416
What this trial is testing

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures

Who this might be right for
Epilepsy, Tonic-Clonic
GlaxoSmithKline 153
Large-scale testing (Phase 3)Looking for participantsNCT06579573
What this trial is testing

ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

Who this might be right for
Epilepsy, Generalized
Ono Pharmaceutical Co., Ltd. 15
Not applicableStudy completedNCT04202159
What this trial is testing

Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures

Who this might be right for
Seizures
Eisai GmbH 187
Testing effectiveness (Phase 2)Study completedNCT00210652
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT03754582
What this trial is testing

Intravenous Perampanel in Japanese Participants With Epilepsy

Who this might be right for
EpilepsySeizures
Eisai Co., Ltd. 21
Large-scale testing (Phase 3)Enrolling By InvitationNCT03961568
What this trial is testing

Cenobamate Open-Label Extension Study for YKP3089C025

Who this might be right for
Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy
SK Life Science, Inc. 145
Load More Results